On today's Cannabis Boomer's Journal of News and Reviews in Cannabis Science, Dr. Alex Terrazas PhD gives his take on the latest findings in cannabis research. Florida Moves to Restrict Medical Marijuana Use in Vehicles A new bill has been introduced in the Florida Senate that aims to crack down on the transportation of open cannabis products. The proposed legislation would make it illegal for both drivers and passengers to have open containers of medical marijuana, hemp, or THC-infused products in their vehicles. Patient advocates warn that it could create significant hardships for the state's nearly 1 million registered medical marijuana users. DEA Delays Cannabis Rescheduling Decision Despite Executive Order The Drug Enforcement Administration has confirmed that the process to reschedule cannabis remains in limbo, despite a recent executive order from President Trump directing the attorney general to complete the reform "in the most expeditious manner." The delay stands in contrast to the DEA's moves to increase production quotas for psychedelics like psilocybin and DMT. Delaware Decriminalizes Public Marijuana Smoking The state of Delaware has passed a bill that decriminalizes the public consumption of marijuana. Individuals caught smoking marijuana in public will face a civil fine of $100, rather than criminal charges. Supporters of the bill argue that this move will help address racial disparities in marijuana-related arrests and destigmatize the use of the drug. Real-world efficacy and safety of CBD in developmental and epileptic encephalopathies This study found that CBD was effective in reducing seizure frequency across various developmental and epileptic encephalopathies, including off-label indications, and was generally well-tolerated, with adverse events being mostly mild to moderate in severity. Rethinking Alzheimer's: Harnessing CBD to Modulate I D O and c GAS Pathways for Neuroinflammation Control This study investigated how CBD independently influences two key neuroinflammatory regulators in Alzheimer's disease. The findings support CBD as a potential monotherapy or adjunctive treatment for Alzheimer's Disease by targeting distinct neuroinflammatory pathways. CBD as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function This research article explores the potential of CBD as a therapeutic agent for Alzheimer's disease, focusing on its ability to mitigate disease pathology and enhance cognitive function. The key findings indicate that CBD exhibits neuroprotective effects, reduces neuroinflammation, and improves cognitive performance in Alzheimer's disease models. #CannabisBoomer

#THC #CBD #CannabisScience #MedicalMarijuana #Alzheimer'sDisease #Epilepsy #CBD #DEA #Rescheduling #PublicConsumption #Florida #Delaware #Research #Science #BabyBoomers #OlderAdults